Immediate Impact
5 from Science/Nature 50 standout
Citing Papers
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
2023 Standout
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population
2023 Standout
Works of R Spanedda being referenced
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma
2002
Exposure to myelotoxic agents and myelodysplasia: case–control study and correlation with clinicobiological findings
1998
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| R Spanedda | 285 | 172 | 96 | 150 | 34 | 463 | |
| Kun Ru | 198 | 121 | 137 | 178 | 48 | 460 | |
| A. Fateh-Moghadam | 261 | 209 | 91 | 165 | 39 | 555 | |
| Pierre Hirsch | 284 | 138 | 151 | 143 | 39 | 546 | |
| Shay Shemesh | 161 | 160 | 105 | 70 | 24 | 557 | |
| M Boasson | 294 | 181 | 96 | 138 | 35 | 532 | |
| Rosella Matera | 250 | 147 | 181 | 121 | 27 | 465 | |
| J. L. Michaux | 261 | 81 | 145 | 155 | 30 | 550 | |
| Edward Peres | 334 | 127 | 159 | 71 | 39 | 543 | |
| M Gaspard | 171 | 170 | 38 | 84 | 28 | 465 | |
| Konstantin Schlick | 110 | 245 | 78 | 104 | 34 | 507 |
All Works
Loading papers...